Apixaban in Patients With Sickle Cell Disease
Clinical trial NCT02179177 · TERMINATED
Trial details
- NCT number
- NCT02179177
- Sponsor
- Nirmish Shah
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-09-03
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.